Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says

Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says

Weight-loss drugs could fuel huge gains for the anti-obesity market, according to Goldman Sachs.Getty Images <ul> <li>The anti-obesity market could become a $100 billion industry by 2030, Goldman Sa… [+2212 chars]

Read More
Top